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ABSTRACT: Organic chemists are able to synthesize molecules in greater number and
chemical complexity than ever before. Yet, a majority of these compounds go untested in
biological systems, and those that do are often tested long after the chemist can incorporate
the results into synthetic planning. We propose the use of high-dimensional “multiplex”
assays, which are capable of measuring thousands of cellular features in one experiment, to
annotate rapidly and inexpensively the biological activities of newly synthesized compounds.
This readily accessible and inexpensive “real-time” proﬁling method can be used in a
prospective manner to facilitate, for example, the eﬃcient construction of performance-
diverse small-molecule libraries that are enriched in bioactives. Here, we demonstrate this
concept by synthesizing ten triads of constitutionally isomeric compounds via complexity-
generating photochemical and thermal rearrangements and measuring compound-induced
changes in cellular morphology via an imaging-based “cell painting” assay. Our results
indicate that real-time biological annotation can inform optimization eﬀorts and library
syntheses by illuminating trends relating to biological activity that would be diﬃcult to
predict if only chemical structure were considered. We anticipate that probe and drug discovery will beneﬁt from the use of
optimization eﬀorts and libraries that implement this approach.
■ INTRODUCTION
Synthetic chemists routinely perform deep and comprehensive
spectral characterization of compounds synthesized in the
laboratory, often within 24 h of synthesis. However, it may take
a year or more to learn if those compounds bind macro-
molecules or have unique biological activities in cells or
animals.1 We recently reported that scientists at the Broad
Institute used 130 cell-based assays to learn retrospectively
about the performance of their synthetic compounds (ca. 100k
prepared using diversity-oriented synthesis) four years after the
syntheses were complete.1 If, instead, chemists could “annotate”
their synthetic products in real time, within days of synthesis
and using large numbers of multiplexed biological measure-
ments, this critical delay in information feedback could be
shortened from years to days. Despite the dramatically
shortened time scale, this method would be capable of
annotating each compound with thousands of measurements
relating to cellular performance across multiple concentrations
(Figure 1). While biological annotation may not be suﬃciently
granular to identify precise molecular targets consistently, it can
reveal which molecules are bioactive. Furthermore, compar-
isons with reference compounds having known activities can
inform whether “actives” function by known or novel
mechanisms of action (MoA) and generate hypotheses for
follow-up MoA studies.2,3 This real-time capability would
provide a more immediate understanding of the consequences
of speciﬁc chemical transformations on the biological perform-
ance of the resulting compounds.4 The resulting proﬁles would
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Figure 1. Schematic representation of concurrent structural assign-
ment and biological annotation of compounds immediately following
their synthesis.
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provide high-dimensional vector representations of the
response of the cells, if any, to a given perturbagen, permitting
rich comparisons of cellular responses using vector algebra.
Systematically coupling synthetic reactions with immediate
biological annotation of reaction products could also facilitate
the discovery of novel small-molecule drugs and probes.
Whereas physicochemical descriptors are often inadequate
predictors of biological performance, data from high-dimen-
sional cell-based assays can provide a “snapshot” of a
compound’s activity in multiple biological contexts. This
capability would enrich optimization eﬀorts that often focus
on a few key metrics (e.g., potency or speciﬁcity) by
determining whether underlying cellular mechanisms have
unwittingly been changed. Only through routine biological
annotation can collections of small molecules be curated such
that individual members (or, ideally, small sets of compounds
sharing similar biological proﬁles) have distinct MoA, whether
they be known or novel. Thus, real-time biological annotation
of synthetic and natural compounds is central to generating
performance-diverse compound collections.1
Providing immediate feedback to chemists, having a better
understanding of the molecular consequences of structural
alterations during optimization, and delivering performance-
diverse compound libraries all address another key challenge in
modern therapeutics discovery. Human biology, especially the
discovery of risk and protective gene variants and the
determination of the altered activities of the corresponding
variant proteins, aﬀords a blueprint for the activities that drugs
should confer on their targets to be safe and eﬀective. Thus,
prior to launching a drug-discovery project, we can know the
consequences of modulating a target in the context of human
physiology.5 But the insights gained thus far suggest that these
modulations demand challenging mechanisms of action not yet
seen in drug discovery. Novel MoA (nMoA) compounds are
needed in order to translate insights from human biology into
safe and eﬀective therapeutic agents, and real-time annotation
concurrent with synthesis may help to identify candidate nMoA
compounds.
Here, we illustrate an experimental and analytical f irst step
toward these challenging goals. A pilot study was performed
using triads of constitutional isomers that, within triads, diﬀer
simply in the arrangement of their atoms and, across triads,
diﬀer in the appendages of three isomeric skeletons. Extending
an earlier retrospective analysis,1,6 we used a multiplexed “cell
painting” assay to measure changes in 1140 cell-morphology
features induced by compound treatment and examined the
eﬀects of varying concentration on these measurements.7 Our
goal is to use this analysis prospectivelyto select perform-
ance-diverse compounds for use in future cell-based screens.
The results, derived from real-time biological annotation of
synthetic reaction products, reinforce the idea that rearranging
the bond connectivity of constitutional isomers can dramati-
cally alter their biological activity, and support the notion that
similarity between chemical structures correlates poorly with
their biological performance. In the process, we discovered a set
of biologically active quaternary nitriles that induce striking
Table 1. Overall Synthetic Scheme and Enumeration of Ten Triads of Skeletally Isomeric Compoundsa
aSites of diversiﬁcation are marked with a blue dot. Yields of transformations leading to skeletal isomers are indicated in parentheses below the
corresponding structures.
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changes in cell morphology. Adopting and extending the
concept of real-time biological annotation to additional types of
measurements (e.g., gene expression and in-cell protein
binding) should advance chemical biology, facilitate the
construction of performance-diverse compound libraries in
the future, and enhance the ability of chemists to contribute to
challenging problems posed by modern biology.8
■ RESULTS
Synthesis of Skeletally Isomeric Triads. We designed
our pilot compound collection (Table 1) to explore the eﬀect
of diﬀering skeletons and appendages on compound activity in
cells. Synthesizing and annotating triads of constitutionally
isomeric compounds controls for variable atom composition
within skeletons. These skeletons undergo signiﬁcant reorder-
ing of atoms to aﬀord triads comprising a monocyclic pyrrole, a
tricyclic aziridine, and a bicyclic imine (or a structurally related
secondary amine). We refer to the collections of all pyrroles,
aziridines, or imines/amines, irrespective of triad, as distinct
cohorts. The compounds that populate our collection contain
several sites of appendage diversiﬁcation (Table 1), which can
be used to further categorize our compounds. Two such
examples are the identity of the electron-withdrawing
substituent (e.g., ketone, nitrile, ester, or amide) and the
substitution pattern along the homoallyl arm of the pyrroles.
We identiﬁed a photochemical rearrangement of pyrroles to
(racemic) tricyclic aziridines9 as an isomerization that exhibits a
large structural complexity diﬀerential (i.e., it is a complexity-
generating reaction).10 This photoreaction converts relatively
“ﬂat” N-homoallyl-substituted pyrroles with an electron-with-
drawing group at C2 into cup-shaped, tricyclic vinyl aziridines
with three contiguous stereocenters. By a measure developed
by the Böttcher group,11 the diﬀerence in complexity between
the starting material and the product in this reaction is 96 units;
comparatively, intermolecular aldol reactions score 41 units,
and amide formation via the Schotten−Baumann reaction
increases complexity by only 3 units.
While expanding the scope of this powerful transformation,
we noted that these aziridines convert to constitutionally
isomeric endocyclic imines via a type of retro-ene reaction upon
exposure to elevated temperatures.12−14 While there is ample
precedent for the thermal rearrangement of aziridines to
azomethine ylides, transformations of this type have been less
well-documented.15−17 This reagent-free rearrangement can be
performed in a variety of organic solvents (Supporting
Information, Table S1) and opens up several avenues for
further synthetic exploration. Furthermore, the topography of
the substrate allows this reaction to proceed under relatively
mild conditions; the cup-shaped tricyclic skeleton orients the
participating atoms in a conformation that is suitable for a
[1,5]-hydrogen shift, and aziridine opening is accompanied by a
signiﬁcant relief of ring strain.12 A competing eliminative
aziridine opening is observed with certain substrates, aﬀording
secondary amines that contain the same 5,6-fused ring system
that characterizes the imines. Particularly important for our
study, these two transformations dramatically reorganize the
skeletal atoms of their substrates to aﬀord compounds that are
structurally distinct from those in the previous two cohorts.
Based on these two isomerizations, we envisioned a small
library of compounds that were derived from a variety of N-
substituted pyrroles. While it had previously been shown that a
number of appendages on the pyrrole ring do not disrupt the
photochemical rearrangement,9 we additionally discovered that
various sites along the homoallylic alcohol-derived appendage
could also be functionalized. Accordingly, we synthesized a
cohort of ten N-substituted pyrroles to constitute the
foundation of our library (Table 1). The generality of the
subsequent photochemical rearrangement allowed us to
incorporate substantial appendage diversity into our small set
of pyrroles: analogs 1a−10a contain one of four electron-
withdrawing groups at C2 and one of three homoallylic
substituents at N1.
The compounds in the aziridine cohort were then
synthesized by irradiating the pyrroles with 254-nm light in a
Rayonet photoreactor (32 W total power output). The beneﬁts,
particularly with regard to scale, of performing this reaction in a
ﬂow reactor have previously been demonstrated,18,19 but we
achieved comparable yields on hundred-milligram scale using
traditional batch chemistry in quartz round-bottom ﬂasks.
Notably, the methyl group in aziridines 2b, 5b, and 8b
preferentially occupies the exo position, as conﬁrmed by the X-
ray crystal structure of derivative compounds (Supporting
Information, Figure S1). With regard to the complexity-
generating aspect of this reaction, pyrrole 1a has three sp3-
hybridized carbons, no chiral centers, and one ring, whereas
aziridine 1b contains seven sp3-hybridized carbons, three chiral
centers, and three rings. A representation of this diﬀerence can
be visualized by principal moment-of-inertia (PMI) analysis,20
which suggests that the pyrrole and aziridine cohorts occupy
distinct areas of three-dimensional space (Figure 2; Supporting
Information p S82, “Principal moment-of-inertia (PMI)
calculations”).
To ﬁnalize our pilot library, members of the aziridine cohort
were heated to eﬀect the strain-releasing aziridine-to-imine
rearrangement. This transformation can take over 48 h to
achieve complete conversion when performed at 70 °C, but
further raising the temperature increases the rate of undesired
side reactions and degradation pathways. Of note, rather than
Figure 2. Principal moment-of-inertia analysis of newly synthesized
compounds. Individual points indicate the location of a given
conformer (up to ﬁve conformers per compound) in PMI space, as
deﬁned by the ratios of their computed principal moments of inertia
(I1 < I2 < I3). Points near the top-left corner indicate one-dimensional
“rod-like” character, points near the bottom indicate two-dimensional
“disc-like” character, and points near the top-right corner indicate
three-dimensional “sphere-like” character.
Journal of the American Chemical Society Article
DOI: 10.1021/jacs.6b04614
J. Am. Chem. Soc. 2016, 138, 8920−8927
8922
providing imines through the typical [1,5]-hydrogen shift,
aziridines 7b, 8b, and 9b rearranged into secondary amines
upon exposure to elevated temperatures via the competing
eliminative transformation mentioned previously. 1H NMR
spectra of compounds 7c, 8c, and 9c show the “loss” of a
methyl group and the emergence of two exo-methylene peaks
around 4.7 and 4.9 ppm. Weak spin−spin coupling can also be
observed between the exo-methylene protons and the protons
on the allylic methylene group.
As might be expected, PMI calculations indicate that
members of the imine/amine cohort are more similar to
aziridines than pyrroles with regard to three-dimensional shape.
Yet, when taken together, our small library of 30 compounds
covers a wide swath of topographic space (Figure 2). This
outcome highlights the power of strategically designed chemical
pathways and further emphasizes that topographically complex
molecules need not be diﬃcult to synthesize.21,22 Furthermore,
the wide array of molecular architectures contained in our
library allows us to begin to probe the relationship between
three-dimensionality and biological activity in a systematic
manner using cell painting.
Biological Proﬁling via Cell Painting. To perform the
cell-painting assay, U-2 OS cells, which are derived from an
osteosarcoma (bone cancer), were seeded in 384-well plates
and treated with DMSO solutions of compounds in a
concentration-dependent manner (six concentrations ranging
from 3.125 μM to 100 μM). Treatments were performed in
quadruplicate, and DMSO-alone conditions were used as
negative controls. After 24 h, cells were exposed to six
nonantibody-based dyes that stained seven organelles and
cellular compartments (Supporting Information, Table S2).6
The cells were then imaged with an automated, high-
throughput ﬂuorescent microscope across ﬁve channels,
acquiring images at nine sites per well. Once obtained, images
of well sites were processed with CellProﬁler software,23 which
is capable of systematically extracting and quantifying cellular
morphological features (Supporting Information p S66, “Image
analysis and data processing”). For example, characteristics of
nuclei and mitochondria, such as size, shape, and eccentricity,
can be measured using nucleus-speciﬁc (Hoechst) and
mitochondria-speciﬁc (MitoTracker Deep Red) stains, respec-
tively, whereas characteristics of whole-cell architecture can be
illuminated using a cytoskeleton-speciﬁc stain (actin-binding
phalloidin). In this manner, 1140 quantitative features can be
examined on a cell-by-cell basis. By comparing these features to
those exhibited by DMSO-treated cells, we can construct
proﬁles for each compound-treatment condition.
The relative ease with which this assay is performed and its
low associated costs make it an attractive assay to annotate
newly synthesized compounds in high throughput; the most
signiﬁcant costs are dyes and microscope time. Furthermore,
the use of label-free compounds guarantees that entire classes
of compounds are not precluded from screening because they
lack a suitable derivatization point. It should also be noted that
cell painting may be performed with a wide variety of cell lines
derived from several tissue types, such as HeLa and A549 cells.6
Analysis of Biological Annotation Data. Having
generated the proﬁles for all concentrations of the synthesized
compounds (Supporting Information p S66, “Biological
proﬁles”), we ﬁrst determined which compounds could be
considered “active” by identifying the compounds that
exhibited proﬁles signiﬁcantly diﬀerent from that of DMSO
alone (Figure 3). To arrive at an “activity score,” we needed a
measure of the distance between two populations (DMSO and
treatment) in a 1140-dimensional feature space. One such
measure is Mahalanobis distance,24 which is analogous to the
Euclidean distance between two points in a lower-dimensional
space and also accounts for the spread of each population and
the colinearity between features (to avoid “overcounting”
redundant features).25 Using this metric, we calculated the
activity scores for each compound treatment condition (e.g., 8b
at 25 μM; Supporting Information p S82, “Compound activity
calculation”). For the purposes of this analysis, compounds
with an activity score greater than 8 were deemed “active.”
Compounds that reduced cell count (perhaps by death,
reduced proliferation, or surface detachment) tended to exhibit
a high activity score; this result is unsurprising as these
processes are often accompanied by drastic changes in cell
morphology. By this assessment, 7 of the 30 compounds were
found to be active at one or more concentrations (4b, 4c, 5b,
5c, 6c, 10a, and 10b). These active compounds revealed an
enrichment of aziridines and imines compared to pyrroles.
Separating compounds by cohort (pyrrole, aziridine, imine/
amine) and taking the average signal from all six compound
concentrations allows this trend to be seen more clearly (Figure
4). The six most active compounds (4b, 4c, 5b, 5c, 6c, 10b)
belong to the aziridine or imine/amine cohort, a result that is
consistent with the notion that sp3-rich molecules that are
topographically complex exhibit more favorable protein-binding
properties than ﬂat, sp2-rich compounds.26 One potential
Figure 3. Dot plot depicting compound activities compared to DMSO
alone. Activity scores describe the degree to which compound-induced
morphological changes are distinct from those induced by DMSO
alone and are calculated according to the distance metric described by
Mahalanobis.24 Each point represents a single compound-treatment
condition (compound A, concentration X), averaged across four
replicates. The dashed line indicates the cutoﬀ at which compound
treatment conditions were considered “active”.
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confounding factor is that aziridines and imines are often
considered to be reactive functional groups that might impart
promiscuous activity. However, not all aziridines or imines are
active in our assay, suggesting that a more nuanced and context-
dependent mechanism is responsible for these results. We also
note that pyrrole motifs can be found in a wide variety of
bioactive molecules,27 suggesting that the pyrrole cohort’s
relative lack of activity cannot be explained solely by the
presence of a pyrrole ring.
While it may be tempting to focus primarily on the
compounds that elicit the strongest cellular responses, a brief
survey of our inactive compounds shows that cell painting is
capable of reliably distinguishing between constitutional
isomers. Even when resorting to a binary active/inactive
designation, we see that many triads contain both active and
inactive compounds. This outcome may be unsurprising
many chiral compounds, for example, exhibit dramatically
diﬀerent activities from their enantiomersbut it provides
further support that high-dimensional annotation is a valuable
tool for compound characterization.
We further analyzed the compound proﬁles to determine if
we could extract more nuanced insights into MoA. Pearson
correlation coeﬃcients were calculated between each pair of
compounds, and the resulting pairwise correlations summarize
the degree to which compounds’ patterns of induced changes in
cell morphology correlate to one another (Figure 5; Supporting
Information p S82, “Heat map generation and clustering”).
Although we see a variety of relationships, the most striking
feature of this analysis is the strong correlation between the six
compounds in the shortest clade of the distance dendrogram
(top-right corner of the heat map, as rendered), which
correspond to the six compounds that we previously identiﬁed
to be the most active (Figure 4). Strikingly, ﬁve out of these six
compounds contain a nitrile connected to a quaternary sp3-
hybridized carbon (only one of the nitrile-containing aziridines
or imines did not score as active at any concentration). While it
remains unclear how the nitrile motif may be inﬂuencing
compound activity in this instance, previous studies have
identiﬁed several classes of bioactive nitriles.28 Mechanistically,
bioactive nitriles are capable of behaving as electrophiles or
hydrogen-bond acceptors. It has also been recognized that
nitriles lacking α-protons are appealing from the standpoint of
their resistance to oxidative metabolism.29
While these active compounds were found to exhibit distinct
activities from the other members of our library, we attempted
to resolve these activities from each other by exploiting the
often nonlinear eﬀects of varying compound concentration.30
For example, we imagine compounds having a single target
showing linear changes in measurements relative to those
having multiple targets with varying aﬃnities. To this end, we
performed a principal component (PC) analysis of the
individual replicates of the active concentrations of six
compounds (Figure 5); focusing on the ﬁrst two principal
components (Figure 6) reveals several noteworthy observa-
tions. First, the spread between replicates in this PC-space is
minor compared to the distances between diﬀerent treatment
conditions. This high level of reproducibility allows us to
distinguish between distinct compound-induced phenotypes,
even for seemingly highly correlated compounds. Second,
analyzing the activities of separate concentrations aﬀords
additional insights into biological activity. In particular, we
note that three concentrations of 5c (25, 50, and 100 μM) form
their own cluster, which indicates that 5c is likely acting via a
distinct cellular MoA from the other ﬁve compounds.
Compounds whose concentrations exhibit dissimilar proﬁles
(e.g., 6c) could indicate a polypharmacological eﬀect in which
additional cellular targets are being engaged at higher
concentrations.
To illustrate representative cellular images, we have high-
lighted the visual diﬀerences between DMSO alone-, imine 5c-,
and aziridine 10b-treated cells (Figure 7). The cell-morpho-
logical changes induced by 5c were particularly striking: cells
exhibited ﬁlopodium-like protrusions31 that were observable in
multiple channels, but most prominently in the Short Red
channel (642 nm, cytoskeleton-stained). Another noticeable
diﬀerence was the apparent “softening” of subcellular compart-
ments near the nuclei, which can be best seen in the Short Red
(642 nm, cytoskeleton-stained) and Long Red (692 nm,
mitochondria-stained) channels. These images not only provide
conﬁrmation that 5c and 10b dramatically alter cell
morphology (indicated by their high activity scores) but also
do so in diﬀerent ways, as suggested by PC analysis (Figure 6).
Follow-up experiments that incorporate additional types of
multiplexed measurements may be performed to gain deeper
insights into this peculiar phenotype. One next step will be to
compare the cell-painting proﬁle of 5c to the proﬁles of known
MoA compounds that have been annotated in this fashion.1 By
analogy to our earlier study, this process should allow us to
distinguish known mechanism-of-action compounds from ones
having novel mechanisms of action (kMoA vs nMoA). These
insights are key to creating performance-diverse compound
collections for cellular or organismal phenotype-based screens.
Of course, another potential direction is to drill deeper into
the newly uncovered activities of compounds with potential for
having novel mechanisms of action. Additional analogs of 5c
may be synthesized and annotated to generate more robust
structure−activity relationships, establishing a valuable feedback
loop between synthetic chemistry and biological performance.
This type of analysis may also be performed with any
compound known to elicit a particular phenotype of interest,
Figure 4. Bar graph of compound activities reveals contributions from
both skeleton and appendage identities. Activity scores for each
compound were averaged across replicates of all concentrations.
Compounds are grouped by cohorts and colored by triads, with
diﬀering shades of a given color indicating a shared electron-
withdrawing group (blue, acetyl; green, nitrile; salmon, ester; gray,
amide). Representing the data in this format emphasizes the inﬂuence
of both skeletons and appendages on biological activity. In particular,
the combination of a nitrile appendage on an aziridine or imine/amine
skeleton yields highly active compounds.
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potentially expediting the challenging task of identifying the
target(s) of a bioactive small molecule.
■ DISCUSSION
Small-molecule collections used in screening and selection
experiments often facilitate the discovery of new chemical
probes and therapeutics. Since some screens of compound
libraries provide unsatisfying results, including yielding no
starting points for further investigation, there is a widespread
view that larger libraries are better than smaller ones. But this
premise may be false if the primary eﬀect of increasing the size
of a library is to increase performance redundancyadding
compounds that either have no eﬀects or have actions that
mirror those of existing library members. We have advocated
for a diﬀerent approach: creating compound libraries in which
each member (ideally, small subsets of molecules) functions by
a distinct MoA. This strategy allows libraries, regardless of size,
to achieve vastly greater levels of performance diversity and
functionality, so long as unique MoA compounds can be
discovered eﬃciently.1 Our work here represents an advance
toward this goal, among others.
Because of the often-substantial temporal disconnection
between chemical synthesis and biological testing, most
modern library generation has been guided by chemical
structures and their associated physical properties. The hope
has been that structural diversity will yield performance
diversity. However, it has been demonstrated that these
structural descriptors are often insuﬃcient predictors of
biological performance (in our recent study, no better than
random chance)1 and that data from high-dimensional cellular
assays may better inform a compound’s activity in biological
contexts.32 Applying readily accessible and inexpensive assays in
real time could greatly facilitate cellular mechanism-informed
optimization of compounds and the design and synthesis of
performance-diverse screening collections by providing rapid
feedback on compound activity. Just as synthetic chemists
annotate each compound with an ensemble of spectroscopic
techniques to establish its structure, broad arrays of phenotypic
measurements could provide critical insights into its biological
function in a matter of days. Conversely, it would take several
Figure 5. Heat map showing relationships of compounds (compound vs compound) based on the similarities of their biological proﬁles. Biological
proﬁles are compared using pairwise Pearson correlation coeﬃcients, calculated from the patterns of cell morphology changes (1140 total features)
induced by compound treatment (average of six concentrations, each in quadruplicate). Structures of the six most highly correlated compounds (red
clade in top dendrogram) are shown to the right of the heat map.
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years and hundreds of experiments to reach a similar level of
understanding using the current model for HTS library
synthesis and evaluation.
We have demonstrated a pilot-scale version of this concept
by describing the synthesis of a small collection of compounds
and their real-time biological annotation via cell painting. We
are able to distinguish compounds having little or no eﬀect on
cells from those engendering either known or novel
phenotypes. Furthermore, we see small clusters of compounds
whose actions on cells appear to be related, despite their
structural diﬀerences. Importantly, our analysis was able to
distinguish between not only constitutional isomers but also
compounds that may appear to be more structurally similar,
even to the trained eye. Looking through a broader lens, our
focus on isomeric triads allowed our results to support the
notion that structural complexity is a valuable feature of
molecules that populate HTS compound libraries. Real-time
analysis provides chemists with powerful insights into the
relationship between their chemical intuition and imagination
and the consequences of perturbing cells in novel ways, in a
manner that would be impossible otherwise. Despite the small
size of the compound collection, we were able to identify a
particularly interesting compound that elicits an unusual
phenotype in U-2 OS cells.
We suggest that real-time annotation of synthetic com-
pounds should become a routine aspect of synthetic organic
chemistry in the future as a means to increase the potential of
chemistry to impact biology and medicine. The robustness and
granularity of our results highlight the promise of readily
accessible and inexpensive cell painting as a potential proﬁling
method in the context of real-time biological annotation of
compounds. Similarly, additional annotation methodologies
(such as cellular thermal proteome proﬁling and bar-coded
gene-expression analysis by multiplexed RNA-Seq)33,34 and cell
lines representing a diverse array of cell states35 may be
incorporated to paint a more comprehensive portrait of a given
compound’s biological activity. Not only would performance-
diverse compound collections assembled in this way increase
the chance of discovering compounds with a wide range of
desired activities, they may also assist MoA determination for
any individual compound by incorporating multi-feature
annotations such as those described in this work.36,37 Lastly,
real-time annotation of compounds empowers chemists to
discover the consequences of their chemical reactions well in
advance of the traditional route of waiting and hoping for a
chance observation, most often by a biologist, years later.
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Figure 6. Principal component analysis of compound-induced changes
in cell morphology illuminates diﬀerences in MoAs of active
compounds. Tight clusters of treatment replicates, represented by
individual points and encircled by ellipses, demonstrate the high
reproducibility of compound-induced changes in cell morphology.
Analyzing biological annotation data across various compound
concentrations provides greater resolution with regard to compound
MoA. Points and ellipses (drawn at 95% conﬁdence intervals) are
colored according to compound identities.
Figure 7. Actual images of vehicle-, compound 5c- (25 μM), and
compound 10b-treated (100 μM) cells observed across ﬁve channels.
The images reinforce that the two highly active compounds depicted
have distinct eﬀects on cell morphology, despite their membership in a
distinct clade when compared to all other compounds (cf., Figure 5).
The discrete morphological features best visualized in each channel are
listed below the channel names.
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